课题基金 / 基金详情

Analysis of Intermedilysin in Human Specific Cytolytic Mechanism : Design and Application for Cell Targeting Module.

Analysis of Intermedilysin in Human Specific Cytolytic Mechanism : Design and Application for Cell Targeting Module.
人特异性溶细胞机制中中间素的分析:细胞靶向模块的设计和应用。
批准号:
12672151
负责人:
OHKURA Kazuto
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

OHKURA Kazuto的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Intermedilysin (ILY), a human specific cytolysin secreted by Streptococcus intermedius, is a member of the gene of SLO-family cytolysin (SFC), but differs by exhibiting a low affinity to cholesterol (CHL) in addition to human specificity. We modeled ILY molecule using perfringolysin O (PFO) X-ray data, and observed four domain (domain 1 〜 domain 4) in the molecule. From the analysis of ILY model, the domain 4 seems to be the human cell membrane associated region. Especially, extended-NTD sequence at ILY C-terminal appeared an important factor for human specific cytolysis. Indeed, the NTD-deleted ILY mutant (ΔNTD-ILY) decreased the hemolytic activity for human erythrocytes. Then we considered that the C-terminal NTD should be concerning with the cluster formation on the human cell membrane.Moreover we constructed the antiCEA-antibody conjugated ILY domain4 (antiCEA-ILY4D), and examined the cell delivery system. AntiCEA-ILY4D bind to human erythrocyte (ET) membrane easily, and this ET-AntiCEA-ILY4D module recognized CEA-positive TT cell. Now we are improving these targeting modules.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
Hori, H.: "TX-1123 : An Antitumor 2-Hydroxyaryliden-4-cyclopentene-1, 3-Dione as a Protein Tyrosine Kinase Inhibitor Having Low Mitochondrial Toxicity"Bioorg.Med.Chem.. 10. 3257-3265 (2002)
Hori,H.:“TX-1123:作为具有低线粒体毒性的蛋白酪氨酸激酶抑制剂的抗肿瘤 2-Hydroxyaryliden-4-cyclopentene-1, 3-Dione”Bioorg.Med.Chem.. 10. 3257-3265 (2002
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kasai,S.: "New Antimetastatic Hypoxic Cell Radiosensitizer : Design, Synthesis, and Biological Activities of 2-Nitroimidazole-acetamide, TX-1877, and Its Analogues."Bioorg.Med.Chem.. in press. (2001)
Kasai,S.:“新型抗转移缺氧细胞放射增敏剂:2-硝基咪唑-乙酰胺、TX-1877 及其类似物的设计、合成和生物活性。”Bioorg.Med.Chem.. 正在出版。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ohkura, K.: "Modification of Cell Response to Insulin by Membrane-Acting Agents in Rat White Adipocytes Analysis of Structural Features by Computational Simulation"Bioorg.Med.Chem.. 9. 3023-3033 (2001)
Ohkura, K.:“通过计算模拟分析大鼠白色脂肪细胞中的膜作用剂对胰岛素的细胞反应的结构特征分析”Bioorg.Med.Chem.. 9. 3023-3033 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
18
    Functional analysis of streptococcal toxins
    • 批准号:
      18K06764
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2018
    • 负责人:
      OHKURA Kazuto
    • 依托单位:
    Molecular analysis of streptococcus derived protein factors for application to drug discovery
    • 批准号:
      24590221
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.49万
    • 财政年份:
      2012
    • 负责人:
      OHKURA Kazuto
    • 依托单位:
    Dynamic structure of intermedilysin : Analysis of membrane binding region
    • 批准号:
      15590098
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2003
    • 负责人:
      OHKURA Kazuto
    • 依托单位:
    国内基金
    海外基金
    靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
    诱导性多能干细胞rDNA区基因打靶在线粒体视神经病中的治疗研究
    • 批准号:
      81970829
    • 项目类别:
      面上项目
    • 资助金额:
      55.0万元
    • 批准年份:
      2019
    • 负责人:
      李卓
    • 依托单位:
    Pre-targeting/Click反应介导的自体循环干细胞在心脏缺血损伤修复中的应用及机制研究
    • 批准号:
      81873493
    • 项目类别:
      面上项目
    • 资助金额:
      57.0万元
    • 批准年份:
      2018
    • 负责人:
      沈德良
    • 依托单位:
    以IGF2/IGF1R与SYT/SSX1为靶点治疗滑膜肉瘤的实验研究
    • 批准号:
      81102033
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2011
    • 负责人:
      李大森
    • 依托单位: